Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Technology | Vascular Closure Devices
November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control Vascular Closure ...
Home November 05, 2018
Home
News | Heart Valve Technology

November 2, 2018 — Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are ...

Home November 02, 2018
Home
The FDA cleared an additional indication for rivaroxaban (Xarelto) to reduce the risk of major cardiovascular (CV) events, such as CV death, myocardial infarction (MI) and stroke, in people with chronic coronary or peripheral artery disease (CAD/PAD).
Feature

November 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home November 01, 2018
Home
News | Cardiovascular Ultrasound

October 31, 2018 — Vygon, an international group specialized in single-use medical devices, and French company ...

Home October 31, 2018
Home
News | EP Mapping and Imaging Systems

October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto ...

Home October 29, 2018
Home
News | Pulmonary Embolism

October 23, 2018 — Daniel J. Schimmel, Jr., M.D., MS, a cardiologist at Northwestern Memorial Hospital, recently ...

Home October 23, 2018
Home
News | Angiography

October 17, 2018 — Shimadzu Medical Systems USA and Change Healthcare have entered a partnership through which Shimadzu ...

Home October 17, 2018
Home
Technology | Antiplatelet and Anticoagulation Therapies

October 17, 2018 — The U.S. Food and Drug Administration (FDA) has cleared an additional indication for rivaroxaban ...

Home October 17, 2018
Home
News | Blood Testing

October 16, 2018 — Abbott announced that its High Sensitive Troponin-I blood test has received CE Mark for distribution ...

Home October 16, 2018
Home
News | CT Angiography (CTA)

October 16, 2018 — A new study published in the European Heart Journal[1] shows computed tomography (CT) can be a useful ...

Home October 16, 2018
Home
Blog | Cath Lab

There is a hype cycle surrounding new technologies in all industries, but medicine is unique because of its focus on ...

Home October 16, 2018
Home
Blog | TCT

From a cardiovascular device innovation standpoint, the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference ...

Home October 15, 2018
Home
Bioresorbable stents (BRS) in development presented by Gregg Stone, M.D., during TCT 2017. Several of the players listed on the slider put their BRS development programs on hold after the negative data from the ABSORB III Trial, but a handful of smaller companies are still pushing the technology forward. #TCT #TCT2018
Feature | Stents Bioresorbable | Dave Fornell, Editor

Bioresorbable stent (BRS) technology is not dead, but the unbridled enthusiasm seen two years ago for the technology has ...

Home October 12, 2018
Home
News | Stents Bioresorbable

October 12, 2018 – Reva Medical presented four key data sets demonstrating the capabilities of the company’s Fantom bior ...

Home October 12, 2018
Home
Subscribe Now